Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Ruminant Vaccines Market

Ruminant Vaccines Market Size

  • Report ID: GMI10481
  • Published Date: Jul 2024
  • Report Format: PDF

Ruminant Vaccines Market Size

Ruminant Vaccines Market size accounted for USD 1.9 billion in 2023 and is set to register growth at 6.8% CAGR between 2024 and 2032. Rising global demand for meat and dairy products is driving an increase in the livestock population.

 

This surge highlights the critical need for effective vaccination programs to safeguard animal health and boost productivity. With the prevalence of both emerging and re-emerging livestock diseases, the demand for robust vaccination strategies is further accentuated, fueling market expansion. Moreover, government initiatives, such as funding for research and vaccination campaigns, are pivotal in propelling market growth.

 

Growing awareness among livestock farmers about the benefits of vaccination in preventing diseases and managing herd health supports the expansion of the ruminant vaccines market. The economic importance of livestock farming in many regions makes disease prevention through vaccination essential for sustaining livelihoods and ensuring food security. Additionally, improved veterinary healthcare infrastructure and better access to vaccines, contribute to market growth.

 

Animal vaccines are crucial tools in safeguarding the health of animals. They work by priming the immune system to identify and fight off pathogens, spanning from bacteria and viruses to parasites. These vaccines come in various forms, including live attenuated and inactivated versions, each tailored to combat distinct diseases. By bolstering immunity, these vaccines not only boost animal health and productivity but also play a pivotal role in ensuring food safety and mitigating the financial toll of livestock disease outbreaks.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ruminant vaccines market accounted for USD 1.9 billion in 2023 and is set to register 6.8% CAGR during 2024-2032 driven by the increase in the livestock population.

The attenuated/modified live vaccines segment in the market held 53.2% share in 2023 as they provide quicker protection following vaccination.

North America ruminant vaccines market accounted for USD 744.8 million in 2023 and is expected to reach USD 1.3 billion by 2032 driven by the demand for effective vaccination programs.

Bimeda Biologicals, Boehringer Ingelheim International GmbH, Ceva Santé Animale, CZ Vaccines S.A.U. (Zendal Group), Elanco Animal Health, HIPRA, Indian Immunologicals Ltd., Kyoto Biken Laboratories, Inc., and Merck & Co., Inc. among others.

Ruminant Vaccines Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 334
  • Countries covered: 22
  • Pages: 190
 Download Free Sample